Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia

Clinical Chemistry

Volumn 48, Issue 6, 2002, Pages 818-825

  Krone, Nils ^a   Braun, Andreas ^a   Weinert, Stefanie ^a   Peter, Michael ^a   Roscher, Adelbert A ^a   Partsch, Carl Joachim ^a   Sippell, Wolfgang G ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID 21 MONOOXYGENASE;

ARTICLE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; COST; DNA DETERMINATION; EXON; GENE AMPLIFICATION; GENE CLUSTER; GENE CONVERSION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; PSEUDOGENE;

EID: 0036274380     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.6.818     Document Type: Article

References (36)

1. Congenital adrenal hyperplasia
2. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
3. High frequency of nonclassical steroid 21-hydroxylase deficiency
4. Structure of human steroid 21-hydroxylase genes
5. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene
6. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): Implications for diagnosis, prognosis and treatment
7. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
8. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation
9. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany
10. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
11. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels
12. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants
13. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
14. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia
15. Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: Implications for steroid 21-hydroxylase deficiency
16. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia using the polymerase chain reaction
17. Nonisotopic detection of point mutations in CYP21B gene in steroid 21-hydroxylase deficiency
18. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population
19. Rapid screening method for detecting mutations in the 21-hydroxylase gene
20. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism
21. Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene
22. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene
23. Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction
24. Steroid 21-hydroxylase deficiency: Three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations
25. Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency
26. Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency
27. Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisone
28. Steroid 21-hydroxylase (P450c21): A new allele and spread of mutations through the pseudogene
29. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia
30. Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia
31. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees
32. An overview of molecular diagnosis of steroid 21-hydroxylase deficiency
33. Characterization of frequent polymorphisms in intron 2 of CYP21: Application to analysis of segregation of CYP21 alleles
34. Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency
35. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational age
36. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: Four years' experience